BUGAMED Biyoteknoloji A.Ş. logo — BUGAMED Biyoteknoloji ile atıklar geleceğe dönüşüyor.

BUGAMED Biyoteknoloji A.Ş.

BUGAMED Biyoteknoloji ile atıklar geleceğe dönüşüyor.

Founded 2017 Turkey Turkey 16 employees Seed Total: $210.00K Biotechnology, Manufacturing +1

General Information

Company Name BUGAMED Biyoteknoloji A.Ş.
Founded Year 2017
Location Turkey Turkey
Employees 16
Industries Biotechnology, Manufacturing, Pharmaceutical
Funding Stage Seed
Business Model B2B, D2C, E Commerce
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with BUGAMED Biyoteknoloji A.Ş.. To contact BUGAMED Biyoteknoloji A.Ş., visit bugamed.com.tr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BUGAMED Biyoteknoloji A.Ş. compare?

A PDF of BUGAMED Biyoteknoloji A.Ş. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BUGAMED Biyoteknoloji A.Ş. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BUGAMED Biyoteknoloji A.Ş.

BUGAMED Biyoteknoloji A.Ş., founded in 2017, is a forward-thinking company headquartered in Turkey, operating at the intersection of Biotechnology, Manufacturing, and Pharmaceutical industries. The company leverages expertise in tissue and materials engineering to transform organic waste into high-tech products, aiming to increase local product diversity and reduce reliance on imported biotechnological materials.

With a mission encapsulated by their slogan, "BUGAMED Biyoteknoloji ile atıklar geleceğe dönüşüyor," the company is committed to addressing significant challenges such as biotechnological raw material shortages and enhancing the value of biomaterials through tissue engineering.

In its latest funding round on 01 June 2023, BUGAMED Biyoteknoloji received a $80.00K seed investment from Alesta Yatırım and TRANGELS. This financial backing underscores investor confidence in BUGAMED's innovative approach to biotechnology and its potential to contribute significantly to the sector.

Business keywords: Tissue Engineering, Biomaterials, Waste Transformation, Sustainable Innovation, Organic Waste Utilization, 3D Scaffolds, Collagen Solutions, Hyaluronic Acid, Silk Fibroin, Zero Waste, Local Production, Import Substitution, High-Tech Products

Services & Products

Innovative raw material solutions
Sustainable product development
Scientific innovation in biotechnology

Target Customers

Pharmaceutical industry Medical device manufacturers Cosmetic industry

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $80.00K 2
Alesta Yatırım, TRANGELS
01 Jun 2023
Seed $130.00K 10
Alesta Yatırım, Artal Capital +8
01 Dec 2020

BUGAMED Biyoteknoloji A.Ş. Alternatives & Competitors

View All Alternatives
BUGAMED Biyoteknoloji A.Ş. vs

Biofiber manufacturers revolutionizing tissue engineering and advanced material applications

Grant
16 employees
Biotechnology, Manufacturing
BUGAMED Biyoteknoloji A.Ş. vs

A leading multinational manufacturer of plastic, rubber and silicone components for medical applicat...

78 employees
Manufacturing, Pharmaceutical
BUGAMED Biyoteknoloji A.Ş. vs
ISC Gums
ISC Gums United States

The leading manufacturer of Gum Acacia and developer of Fusion stabilizer and texturizer systems.

11 employees
Food and Beverage, Industrial

FAQ About BUGAMED Biyoteknoloji A.Ş.

BUGAMED Biyoteknoloji ile atıklar geleceğe dönüşüyor.
BUGAMED Biyoteknoloji A.Ş. was founded in 2017.
BUGAMED Biyoteknoloji A.Ş. is headquartered in Turkey.
BUGAMED Biyoteknoloji A.Ş. operates in Biotechnology, Manufacturing and Pharmaceutical. Its work centres on Tissue Engineering, Biomaterials, Waste Transformation and Sustainable Innovation. Its customers include Pharmaceutical industry, Medical device manufacturers and Cosmetic industry.
BUGAMED Biyoteknoloji A.Ş. has a B2B, D2C and E Commerce business model. Its revenue comes from Product Sales, Service Fee and Licensing.
BUGAMED Biyoteknoloji A.Ş. has approximately 16 employees.
BUGAMED Biyoteknoloji A.Ş. has completed 2 funding rounds, raising a total of $210.00K. The latest funding stage is Seed.
BUGAMED Biyoteknoloji A.Ş. offers: Innovative raw material solutions, Sustainable product development, Scientific innovation in biotechnology.
Top alternatives and competitors to BUGAMED Biyoteknoloji A.Ş. include 3DBioFibR Inc., Industrie BORLA S.p.A., ISC Gums, Geltor, Microcyto微元合成. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BUGAMED Biyoteknoloji A.Ş. and 3DBioFibR Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BUGAMED Biyoteknoloji A.Ş., https://bouncewatch.com/company/bugamed, updated 4 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes